Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection
Status:
Terminated
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety and effectiveness of inhaled
Interferon gamma-1b (IFN-g 1b), when administered for 48 weeks and in combination with oral
antibiotics which may be administered for up to 72 weeks for the treatment of a lung
infection caused by a bacterium called Mycobacterium avium complex .
FDA has not approved Interferon gamma-1b for use in patients with MAC infection of the lungs,
which is the purpose of this study.Interferon gamma-1b and similar proteins play important
roles in establishing and maintaining protective immune responses against a variety of
microorganisms.